Table 2.
Clinical and pathological characteristics
| Age (Years) |
Size in uterus (cm) |
LVI | CTNNB1 mutation |
Stage at Presentation |
Treatment | Site(s) of Distant Metastatic Disease |
Length of Follow up (months) |
Survival | |
|---|---|---|---|---|---|---|---|---|---|
| Case 1 | 60 | 1.2 | N | ND | T1bN0M0 | S, C, R | Liver, chest wall, brain | 12 | DOD |
| Case 2 | 65 | 1.7 | Y | CTNNB1 (D32Y) | T1bN0M1 | S, C, R | Bone, lung, soft tissue | 17 | LFU |
| Case 3 | 56 | U | U | ND | M1 | S, C | Liver | 10 | DOD |
| Case 4 | 73 | 3.5 | Y | CTNNB1 (S37F) | T3aN2aM0 | S, C, R | Lung, liver | 14 | DOD |
| Case 5 | 38 | U | U | ND | M1 | NAC | Lung, mediastinal lymph nodes | 1 | AWD |
Abbreviations: AWD: alive with disease; C: chemotherapy; CA: carcinoma; DOD: died of disease; LFU: lost to follow-up; N: no; NAC: neoadjuvant chemotherapy; ND: not done; S: surgery; R: radiation therapy; U: unknown; Y: yes.